NF-kB can act as a tumor suppressor and prevent cancer development through the activation of the Claspin–Chk1-mediated checkpoint response, which, early in carcinogenesis, will prevent the accumulation of genetic mutations [80]. This evidence concerns the gene CLSPN and cancer.